NPRL2 and neoplasm: Individual mouse growth curve showed that after 3 wk of treatment, NPRL2 contained a tumor size below 500 mm3 for 50% of mice (4/8), whereas control, anti-PD1, and combination were 0% (0/9), 11% (1/9), and 25% (2/8) (Figure 5C).